Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.75
-0.05 (-0.16%)
Aug 19, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1092,1622,2002,1501,9401,780
Revenue Growth
-7.50%-1.71%2.31%10.81%9.01%1.44%
Gross Profit
734.2768.86747.79755.56694.9594.47
Operating Income
261.23295.67310.22259.84321.67254.48
Net Income
204.22244.41243.41198.41352196.11
Earnings Per Share
2.032.412.401.963.481.94
EPS Growth
-23.12%0.42%22.45%-43.68%79.38%7.18%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
1,7031,6121,4211,3061,173
Other Countries
67.664.3154.4534.8226.62
Mainland China
209.24239.74407.41184.15362.6
Japan
101.06190.08207.07240.9395.64
United States
81.4593.2460.37174.14122.59
Total
2,1622,2002,1501,9401,780

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
383.56345.67301.54378.48402.51418.41
Total Debt
684.64655.69638.23705.56409.13532.81
Net Cash (Debt)
-301.09-310.02-336.69-327.08-6.62-114.4
Net Cash Growth
------
Net Cash Per Share
-3.00-3.06-3.33-3.23-0.07-1.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
351.2464.08466.43342.61369.19556.63
Capital Expenditures
-206.54-277.82-524.6-297.51-93.84-156.05
Free Cash Flow
144.66186.25-58.1745.1275.35400.58
Free Cash Flow Growth
58.82%---83.62%-31.26%558.08%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.81%35.56%33.99%35.14%35.81%33.40%
Operating Margin
12.38%13.67%14.10%12.08%16.58%14.30%
Pretax Margin
11.52%13.47%13.78%9.94%21.16%13.19%
Profit Margin
9.68%11.30%11.06%9.23%18.14%11.02%
FCF Margin
6.86%8.61%-2.64%2.10%14.19%22.50%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.600-1.6002.0002.3001.800
Dividend Per Share Growth
0%--20.00%-13.04%27.78%12.50%
Dividend Yield
5.03%-4.27%4.28%4.26%5.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.6715.4117.0727.1318.3319.83
Forward PE
-14.9217.9519.6821.3014.55
P/FCF Ratio
22.2020.22-119.3623.449.71
PS Ratio
1.521.741.892.503.332.18